{"id":4000090160,"date":"2026-11-16T16:57:13","date_gmt":"2026-11-16T14:57:13","guid":{"rendered":"https:\/\/new.igihe.com\/french\/?p=4000090160"},"modified":"2026-11-16T16:57:22","modified_gmt":"2026-11-16T14:57:22","slug":"le-rwanda-elargit-sa-campagne-de-vaccination-contre-le-cancer-du-col-de-luterus","status":"publish","type":"post","link":"https:\/\/new.igihe.com\/french\/le-rwanda-elargit-sa-campagne-de-vaccination-contre-le-cancer-du-col-de-luterus\/","title":{"rendered":"Le Rwanda \u00e9largit sa campagne de vaccination contre le cancer du col de l\u2019ut\u00e9rus"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Dans un communiqu\u00e9 conjoint publi\u00e9 ce 16 novembre 2026, le minist\u00e8re de la Sant\u00e9 et le Centre biom\u00e9dical du Rwanda (RBC) ont annonc\u00e9 que le vaccin serait administr\u00e9 gratuitement dans tous les centres de sant\u00e9 du pays. Les b\u00e9n\u00e9ficiaires devront pr\u00e9senter leur carte d\u2019identit\u00e9 ou tout autre document attestant de leur \u00e2ge.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Chaque b\u00e9n\u00e9ficiaire recevra deux doses, la seconde \u00e9tant administr\u00e9e six mois apr\u00e8s la premi\u00e8re.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cette extension vient compl\u00e9ter le programme national de vaccination des jeunes filles \u00e2g\u00e9es de 12 ans, ainsi que les services de d\u00e9pistage du cancer du col de l\u2019ut\u00e9rus propos\u00e9s aux femmes de diff\u00e9rentes tranches d\u2019\u00e2ge.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Le minist\u00e8re de la Sant\u00e9 et le RBC soulignent que cette maladie peut \u00eatre largement pr\u00e9venue et trait\u00e9e lorsqu\u2019elle est d\u00e9tect\u00e9e pr\u00e9cocement. Selon les donn\u00e9es du RBC, elle constitue le deuxi\u00e8me cancer le plus fr\u00e9quent chez les femmes au Rwanda et repr\u00e9sente 13 % de l\u2019ensemble des cas de cancer dans le pays.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dans le cadre de sa strat\u00e9gie \u00ab Mission 2027 \u00bb, lanc\u00e9e en f\u00e9vrier 2025, le Rwanda ambitionne d\u2019\u00e9liminer le cancer du col de l\u2019ut\u00e9rus en tant que probl\u00e8me de sant\u00e9 publique d\u2019ici 2027, soit trois ans avant l\u2019\u00e9ch\u00e9ance mondiale fix\u00e9e par l\u2019OMS. Le pays pr\u00e9voit notamment de d\u00e9pister 70 % des femmes \u00e2g\u00e9es de 30 \u00e0 49 ans et d\u2019assurer un traitement \u00e0 90 % de celles pr\u00e9sentant des l\u00e9sions pr\u00e9canc\u00e9reuses ou un cancer.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Le Rwanda avait introduit la vaccination contre le papillomavirus humain (HPV), responsable de la quasi-totalit\u00e9 des cancers du col de l\u2019ut\u00e9rus, en 2011, devenant ainsi le premier pays africain \u00e0 mettre en place un programme national en la mati\u00e8re. La couverture vaccinale des jeunes filles d\u00e9passe r\u00e9guli\u00e8rement 90 %.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00c0 l\u2019\u00e9chelle mondiale, l\u2019OMS recommande aux pays d\u2019atteindre les objectifs dits \u00ab 90-70-90 \u00bb d\u2019ici 2030. Ceux-ci pr\u00e9voient que 90 % des filles soient compl\u00e8tement vaccin\u00e9es contre le HPV avant l\u2019\u00e2ge de 15 ans, que 70 % des femmes b\u00e9n\u00e9ficient d\u2019un d\u00e9pistage \u00e0 l\u2019aide d\u2019un test performant \u00e0 35 ans, puis \u00e0 45 ans, et que 90 % des femmes pr\u00e9sentant des l\u00e9sions pr\u00e9canc\u00e9reuses ou un cancer re\u00e7oivent un traitement appropri\u00e9.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L\u2019OMS rappelle que le cancer du col de l\u2019ut\u00e9rus peut \u00eatre \u00e9vit\u00e9 gr\u00e2ce \u00e0 la vaccination et trait\u00e9 efficacement lorsqu\u2019il est d\u00e9tect\u00e9 \u00e0 un stade pr\u00e9coce.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1000\" height=\"666\" src=\"https:\/\/cdn.igihe.com\/fr\/2026\/11\/VACC.jpg\" alt=\"\" class=\"wp-image-4000090162\" srcset=\"https:\/\/cdn.igihe.com\/fr\/2026\/11\/VACC.jpg 1000w, https:\/\/cdn.igihe.com\/fr\/2026\/11\/VACC-300x200.jpg 300w, https:\/\/cdn.igihe.com\/fr\/2026\/11\/VACC-768x511.jpg 768w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><figcaption class=\"wp-element-caption\">Le Rwanda a \u00e9largi son programme de vaccination contre le cancer du col de l\u2019ut\u00e9rus aux femmes et aux jeunes filles \u00e2g\u00e9es de 30 \u00e0 45 ans<\/figcaption><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Le Rwanda a \u00e9largi son programme de vaccination contre le cancer du col de l\u2019ut\u00e9rus aux femmes et aux jeunes filles \u00e2g\u00e9es de 30 \u00e0 45 ans, dans le cadre des efforts visant \u00e0 \u00e9liminer cette maladie d\u2019ici 2027.<\/p>\n","protected":false},"author":452,"featured_media":4000090161,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"archived_slugs":[],"footnotes":"","igh_game_id":0},"categories":[7546],"tags":[9962,7600],"byline":[7717],"hashtag":[],"class_list":["post-4000090160","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sante-20","tag-editors-choice","tag-highlights-home","byline-igihe"],"bylines":[{"id":7717,"name":"IGIHE","slug":"igihe","description":"","image":{"id":0,"url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&f=y&r=g","alt":"Default avatar","title":"Default avatar","caption":"","mime_type":"image\/jpeg","sizes":[]},"user_id":393,"twitter_handle":""}],"contributors":[{"id":7717,"name":"IGIHE","slug":"igihe","description":"","image":{"id":0,"url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&f=y&r=g","alt":"Default avatar","title":"Default avatar","caption":"","mime_type":"image\/jpeg","sizes":[]},"user_id":393,"twitter_handle":""}],"featured_image":{"id":4000090161,"url":"https:\/\/cdn.igihe.com\/fr\/2026\/11\/VACC-CP.jpg","alt":"","caption":"","mime_type":"image\/jpeg","width":800,"height":533,"sizes":{"thumbnail":{"url":"https:\/\/cdn.igihe.com\/fr\/2026\/11\/VACC-CP-150x150.jpg","width":150,"height":150},"medium":{"url":"https:\/\/cdn.igihe.com\/fr\/2026\/11\/VACC-CP-300x200.jpg","width":300,"height":200},"medium_large":{"url":"https:\/\/cdn.igihe.com\/fr\/2026\/11\/VACC-CP-768x512.jpg","width":768,"height":512},"large":{"url":"https:\/\/cdn.igihe.com\/fr\/2026\/11\/VACC-CP.jpg","width":800,"height":533},"full":{"url":"https:\/\/cdn.igihe.com\/fr\/2026\/11\/VACC-CP.jpg","width":800,"height":533}}},"_links":{"self":[{"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/posts\/4000090160","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/users\/452"}],"replies":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/comments?post=4000090160"}],"version-history":[{"count":1,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/posts\/4000090160\/revisions"}],"predecessor-version":[{"id":4000090163,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/posts\/4000090160\/revisions\/4000090163"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/media\/4000090161"}],"wp:attachment":[{"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/media?parent=4000090160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/categories?post=4000090160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/tags?post=4000090160"},{"taxonomy":"byline","embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/byline?post=4000090160"},{"taxonomy":"hashtag","embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/hashtag?post=4000090160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}